Findings
========

HIV-infected people are at increasing risk of developing several non-AIDS defining illnesses, including diabetes mellitus (DM) and cardiovascular diseases \[[@B1]-[@B3]\]. Traditional risk factors (such as cigarette smoking, ageing, obesity, and viral co-infections) and duration of HIV infection are considered responsible of their elevated frequency, though they have also been associated with adverse effects of antiretroviral treatments \[[@B1],[@B4]-[@B6]\]. Several studies have evaluated the incidence of DM and cardiovascular diseases in HIV-infected persons in the era of highly active antiretroviral therapies (HAART), and their impact as causes of death \[[@B7]-[@B10]\].

By taking advantage of the population-based data used for assessing post-AIDS survival \[[@B11]\], we estimated the risk of death for DM, myocardial infarction, and chronic ischemic heart diseases among people with AIDS diagnosed between 1999 and 2005. The original study design and the main characteristics of study subjects were previously described \[[@B11]\]. Briefly, in Italy AIDS cases are diagnosed according to the 1993 revised European AIDS definition \[[@B12]\], and they are compulsorily reported to the national AIDS registry (RNAIDS), a comprehensive surveillance system formerly described in detail \[[@B13]\]. Under-reporting of people with AIDS (PWA) has been estimated at about 5% \[[@B14]\], whereas the vital status of PWA is not routinely kept up-to-date. The updated vital status of PWA was sought for in the Italian Mortality Database at the Italian National Institute of Statistics through a record linkage procedure. Data regarding PWA diagnosed in Italy from 1999 and 2005 were linked with data concerning the 4,420,498 deaths occurred between 1999 and 2006. After excluding non Italian citizens, pediatric cases, PWA diagnosed solely at autopsy who were residents in provinces where information on names were not available on deaths certificates, 9662 Italian adult PWA constituted the study population. Of these PWA, 3101 died. Conditions listed in the death certificate were classified as AIDS- or non-AIDS-related based on the presence/absence of an AIDS-defining condition according to the 1993 revised European AIDS definition \[[@B12]\].

Deaths certificates reporting DM, myocardial infarction, and chronic ischemic heart diseases in any position were reviewed by study members to distinguish when one of these conditions was the underlying cause of death (i.e., the disease which initiated the sequence of morbid events leading directly to death) or a contributing one. This process was undertaken to properly compare the observed numbers of DM, myocardial infarction, and chronic ischemic heart diseases as underlying cause of death in PWA with the expected numbers from the sex- and age-matched, general population of Italy. The codification rules of the International Classification of Diseases, tenth revision (ICD-10), were applied.

We took into consideration all ICD-10 codes pertaining to DM (i.e., E10-E14), while for cardiovascular causes of death, we focused on acute myocardial infarction (ICD-10, I21) and chronic ischemic heart diseases (ICD-10, I25), two important and well diagnosed conditions.

Person-years (PY) at risk of death were computed from date of AIDS diagnosis up to date of death or to December 31, 2006. The number of observed deaths due to DM, myocardial infarction, or chronic ischemic heart diseases was divided by the expected one, computed from age and sex specific mortality rates from the Italian general population in the same period. Thus, standardized mortality ratios (SMR) and their 95% confidence intervals (CI) were computed \[[@B15]\].

The 9,662 AIDS cases included in this study summed up to 34,814 PY of follow-up and 3,101 deaths. The most frequent conditions listed in death certificates were hepatic diseases (reported in 31.0% of death certificates), AIDS-associated opportunistic infections (29.2%), other infectious diseases not included in the AIDS definition (24.1%), non-Hodgkin lymphoma (14.6%), and Kaposi sarcoma (4.3%) (data not shown).

DM and cardiovascular diseases were the underlying cause of death of 43 PWA (i.e., they cause 1.4% of all deaths): 14 deaths were caused by DM, 17 by myocardial infarction, and 12 by chronic ischemic heart diseases Table [1](#T1){ref-type="table"}. The corresponding SMR were 6.4 for DM (95% CI:3.5-10.8), 2.3 for myocardial infarction (95% CI:1.4-3.7) and 3.0 for chronic ischemic heart diseases (95% CI: 1.5-5.2).

###### 

Standardized mortality ratios of dying from diabetes mellitus, myocardial infarction, or chronic ischemic heart diseases in people with AIDS, according to selected characteristics. Italy, 1999-2006

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                         Cause of death                                                                                                                                   
  --------------------------------------------- -------- ----------------------- --------------------------- ------------------------------------- --------- --------- -------------- --------- --------- --------------
                                                         **Diabetes mellitus**   **Myocardial infarction**   **Chronic ischemic heart diseases**                                                          

                                                                                                                                                                                                          

                                                **PY**   **Obs**                 **Exp**                     **SMR**\                              **Obs**   **Exp**   **SMR**\       **Obs**   **Exp**   **SMR**\
                                                                                                             **(95% CI)**                                              **(95% CI)**                       **(95% CI)**

                                                                                                                                                                                                          

  **Age at AIDS diagnosis**\                                                                                                                                                                              
  **(n° of cases)**                                                                                                                                                                                       

   \<45 (6958)                                  26389    5                       0.36                        13.8\                                 4         1.97      2.0\           4         0.51      7.8\
                                                                                                             (4.4-32)                                                  (0.5-5.2)                          (2.0-20)

   ≥45 (2704)                                   8425     9                       1.82                        4.9\                                  13        5.34      2.4\           8         3.50      2.3\
                                                                                                             (2.2-9.4)                                                 (1.3-4.2)                          (1.0-4.5)

                                                                                                                                                                                                          

  **Sex (n° of cases)**                                                                                                                                                                                   

   Male (7511)                                  26962    14                      1.97                        7.1\                                  14        7.01      2.0\           9         3.81      2.4\
                                                                                                             (3.9-11.9)                                                (1.1-3.4)                          (1.1-4.5)

   Female (2151)                                7851     0                       0.21                        0                                     3         0.30      9.9\           3         0.20      14.9\
                                                                                                                                                                       (1.9-29)                           (2.8-44)

                                                                                                                                                                                                          

  **HIV-transmission category (n° of cases)**                                                                                                                                                             

   Intravenous drug user (4040)                 14235    5                       0.28                        18.2\                                 5         1.42      3.5\           4         0.41      9.7\
                                                                                                             (5.7-43)                                                  (1.1-8.3)                          (2.5-25)

   Homosexual man (1741)                        6512     2                       0.61                        3.3\                                  0         2.08      0              3         1.14      2.6\
                                                                                                             (0.3-12.1)                                                                                   (0.5-7.8)

   Heterosexual (3297)                          12121    5                       1.06                        4.7\                                  10        3.14      3.2\           3         1.99      1.5\
                                                                                                             (1.5-11.1)                                                (1.5-5.9)                          (0.3-4.5)

   Other (584)                                  1945     2                       0.24                        8.5\                                  2         0.67      3.0\           2         0.47      4.2\
                                                                                                             (0.8-31)                                                  (0.3-10.9)                         (0.4-15.6)

                                                                                                                                                                                                          

  **Total (9662)**                              34814    14                      2.18                        6.4\                                  17        7.31      2.3\           12        4.01      3.0\
                                                                                                             (3.5-10.8)                                                (1.4-3.7)                          (1.5-5.2)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SMR = Standardized mortality ratio; PY = Person Years; Obs = Observed; Exp = Expected; CI = Confidence interval

The risk of death associated to DM was more pronounced in younger (SMR = 13.8) than in older individuals (SMR = 4.9), and it was restricted to men Table [1](#T1){ref-type="table"}. An 18-fold higher risk of death for DM was seen among intravenous drug users (IDUs). The risks of death associated with myocardial infarction and with chronic ischemic heart diseases were substantially elevated in women (SMR = 9.9 and SMR = 14.9, respectively), whereas they were of borderline statistical significance in men. A particularly pronounced excess risk was seen for chronic ischemic heart diseases in cases aged less than 45 years at AIDS diagnosis (SMR = 7.8) Table [1](#T1){ref-type="table"}. The SMR for chronic ischemic heart diseases was nearly 10-fold higher in IDUs than in the general population Table [1](#T1){ref-type="table"}

DM, myocardial infarction, and chronic ischemic heart diseases had a marginal impact (i.e., 1.4%) on mortality of Italian AIDS cases in the post-HAART era. However, the risks of death were remarkably higher than in the corresponding general population. We have used mortality rates in the general population as a bench mark for comparison, because the overall mortality of HIV-infected individuals is increasingly influenced by deaths that would have occurred regardless of HIV infection. Although based on small numbers, differences in the magnitude of SMRs according to sex, age and HIV-transmission category seem to point toward multiple risk factors (e.g., smoking for cardiovascular diseases). We have previously demonstrated, among Italian AIDS cases below the age of 55 years, a nearly 5-fold excess death risk for pancreatic cancer \[[@B16]\]. Such observation is in line with the well established role of DM as a risk factor for pancreatic cancer \[[@B17]\]. With regard to myocardial infarction and ischemic heart diseases, the patterns of risk herein described seem to resemble the one seen, in HIV-infected persons, for smoking-related cancers. Our group has recently shown, in Italian AIDS cases, a 4-fold higher risk in men and a 6-fold higher risk in women of developing lung cancer, an excess risk mainly attributed to a high prevalence of smokers in HIV-infected people \[[@B18]\]. As for lung cancer, HIV-infected people are likely to be at higher risk for other smoking-related diseases, because such a habit is more common among them than in the general population.

Possible limitations of this study should be addressed. With regard to the identification of the underlying cause of death, we adopted the same ICD-10 rules of codification used by the Italian National Institute of Statistics for the general population (i.e., without considering the mention of HIV/AIDS). We acknowledge that the quality of death certificates is low and that the ICD-10 rules may be of difficult application to people with severe immunodeficiency, given that these people are at risk of dying from a multitude of other causes. From a statistical viewpoint, the stratified analyses suffered from the small numbers of observed deaths in several subgroups, whereas the analysis regarding the total number of deaths allowed us a finer computation of SMR. Furthermore, the dataset used for this analysis did not include information on individual risk factors; we were, thus, unable to provide further insights in the reasons for this excess risk. Conversely, completeness was the main advantage of population-based investigations, and for this analysis, we used two databases covering the whole Italian population.

In conclusion, DM and cardiovascular diseases caused a statistically significant excess in the number of deaths of AIDS cases. Understanding the causes of such augmented risks will help reduce mortality from non-AIDS defining illnesses. In this perspective, anti-smoking campaigns may be crucial in making antiretroviral treatments more effective.
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